Position in AVXL
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$396,567
+$84,448 QoQ
Shares Held
129,175
+47.3% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. AVXL ranks #79 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503,564 | $224,861,468 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,152 | $84,335,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
171,797 | $56,842,473 | |
| 4 | INSM |
INSMED Inc
|
299,925 | $49,043,736 | |
| 5 | ARGX |
Argenx SE
|
61,418 | $44,850,494 | |
| 6 | RPRX |
Royalty Pharma plc
|
495,892 | $23,787,939 | |
| 7 | GMAB |
Genmab A/S
|
862,301 | $23,135,535 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
678,518 | $18,794,948 |
All Filings in AVXL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $396,567 | 129,175 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $312,119 | 87,674 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $533,492 | 59,943 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $457,072 | 49,574 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $454,757 | 53,002 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $634,368 | 59,066 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $217,515 | 38,295 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||